Colin R Green Selected Research

Spinal Injections

1/2018

Attenuation of mechanical pain hypersensitivity by treatment with Peptide5, a connexin-43 mimetic peptide, involves inhibition of NLRP3 inflammasome in nerve-injured mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Colin R Green Research Topics

Disease

31	Inflammation (Inflammations) 04/2024 - 09/2003
10	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 03/2016
9	Wounds and Injuries (Trauma) 01/2021 - 09/2003
9	Ischemia 09/2020 - 01/2012
8	Spinal Cord Injuries (Spinal Cord Injury) 10/2017 - 05/2008
7	Gliosis 12/2023 - 03/2002
6	Hypoxia (Hypoxemia) 09/2020 - 02/2012
5	Chronic Disease (Chronic Diseases) 06/2022 - 04/2014
5	Retinal Diseases 02/2022 - 03/2016
5	Edema (Dropsy) 10/2017 - 12/2011
4	Disease Progression 12/2023 - 01/2014
4	Neuroinflammatory Diseases 12/2023 - 01/2013
4	Necrosis 01/2023 - 05/2004
4	Fibrosis (Cirrhosis) 03/2021 - 08/2012
4	Brain Ischemia (Cerebral Ischemia) 09/2020 - 01/2014
4	Seizures (Absence Seizure) 09/2020 - 03/2002
4	Reperfusion Injury 01/2018 - 05/2004
4	Optic Nerve Diseases (Optic Neuropathy) 10/2015 - 11/2008
3	Brain Injuries (Brain Injury) 06/2022 - 01/2013
3	Eye Diseases (Eye Disease) 01/2022 - 10/2019
3	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 03/2016
3	Cicatrix (Scar) 10/2016 - 01/2006
3	Glaucoma 03/2016 - 08/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2023 - 03/2002
2	Hyperglycemia 12/2020 - 11/2017
2	Geographic Atrophy 01/2019 - 01/2019
2	Ganglion Cysts (Ganglion) 01/2018 - 03/2012
2	Neuralgia (Stump Neuralgia) 01/2018 - 01/2014
2	Nervous System Trauma 01/2016 - 02/2012
2	Optic Nerve Injuries 06/2011 - 11/2008
2	Infarction (Infarctions) 01/2006 - 05/2004
1	Hypertrophy 04/2024
1	Multiple Sclerosis 12/2023
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2023
1	Cognitive Dysfunction 01/2023
1	Chronic Renal Insufficiency 03/2021
1	Retinal Degeneration 02/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020
1	Herpes Zoster 01/2020
1	Aneurysm (Aneurysms) 01/2020
1	Ureteral Obstruction 01/2020
1	Animal Disease Models 10/2019
1	Pathologic Dilatation (Ectasia) 07/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Ischemic Stroke 01/2019
1	Infections 02/2018
1	Peripheral Nerve Injuries 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Pain (Aches) 01/2018
1	Migraine Disorders (Migraine) 10/2017

Drug/Important Bio-Agent (IBA)

50	Connexin 43 (Connexin43)IBA 04/2024 - 03/2002
32	ConnexinsIBA 06/2022 - 03/2002
17	Retinaldehyde (Retinal)IBA 01/2023 - 08/2010
17	Peptides (Polypeptides)IBA 09/2020 - 05/2008
15	InflammasomesIBA 12/2023 - 01/2016
10	Adenosine Triphosphate (ATP)IBA 03/2021 - 01/2013
8	CytokinesIBA 04/2024 - 09/2003
8	Proteins (Proteins, Gene)FDA Link 02/2021 - 03/2002
7	tonabersatIBA 12/2023 - 10/2017
4	OligodeoxyribonucleotidesIBA 08/2012 - 10/2008
3	CalciumIBA 12/2023 - 01/2012
3	NLR ProteinsIBA 01/2023 - 01/2018
3	SolutionsIBA 01/2022 - 01/2018
3	salicylhydroxamic acid (SHAM)IBA 09/2020 - 01/2012
3	Purinergic Receptors (Receptors, Purine)IBA 01/2020 - 01/2014
2	NucleotidesIBA 01/2023 - 10/2019
2	Interleukin-1beta (Interleukin 1 beta)IBA 01/2023 - 01/2021
2	Coloring Agents (Dyes)IBA 01/2020 - 01/2006
2	Glutamic Acid (Glutamate)FDA Link 01/2013 - 01/2012
1	Myelin Basic ProteinIBA 12/2023
1	Glial Fibrillary Acidic ProteinIBA 12/2023
1	Myelin-Oligodendrocyte GlycoproteinIBA 12/2023
1	CollagenIBA 03/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 12/2020
1	gamma-Aminobutyric Acid (GABA)IBA 09/2020
1	IonsIBA 01/2020
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2020
1	Tight Junction ProteinsIBA 01/2020
1	Evans Blue (Blue, Evans)FDA Link 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	6-carboxyfluorescein (carboxyfluorescein)IBA 01/2020
1	Leucine (L-Leucine)FDA Link 10/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Fluorescein-5-isothiocyanate (FITC)IBA 01/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	Small Interfering RNA (siRNA)IBA 11/2016
1	Collagen Type II (Type II Collagen)IBA 10/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2016

Therapy/Procedure

7	Therapeutics 01/2022 - 07/2012
3	Intravitreal Injections 01/2023 - 10/2015
3	Intraventricular Infusions 09/2020 - 01/2014
1	Refractive Surgical Procedures 07/2019
1	Spinal Injections 01/2018
1	Drug Therapy (Chemotherapy) 01/2018